Senores Pharmaceuticals, a leading drug manufacturer, is set to debut on the BSE and NSE today, December 30, 2024, following its highly successful IPO that concluded with a stellar subscription rate of 93.41 times.
IPO Details
- Price Band: ₹372 – ₹391 per share
- Lot Size: 38 shares
- IPO Size: ₹582.11 crore
- Fresh Issue: ₹500 crore
- Offer-for-Sale (OFS): 21,00,000 equity shares
Subscription Breakdown
The IPO witnessed robust participation from all investor categories:
- Qualified Institutional Buyers (QIBs): 94.66 times
- Non-Institutional Investors (NIIs): 96.11 times
- Retail Investors: 89.23 times
- Employees: 19.92 times
Grey Market Premium (GMP)
As of today, Senores Pharmaceuticals is trading at a GMP of ₹284, which suggests a 72.63% premium over the upper price band of ₹391. The expected listing price is around ₹675 per share, reflecting strong investor demand and positive sentiment in the grey market.
Listing Timeline
- Allotment Finalization: December 26, 2024
- Refunds/Unblocking of Funds: December 27, 2024
- Shares Credit to Demat Accounts: December 29, 2024
- Listing Date: December 30, 2024
Expectations for Today
Given the strong GMP and enthusiastic subscription response, Senores Pharmaceuticals is anticipated to deliver a blockbuster listing today. Investors are keenly watching the market performance to assess the stock’s trajectory post-listing.
